Compounds show significant promise against potential bioweapon toxins

Because of the high cost and limited applicability of currently available treatments, the newly identified compounds have the potential to fill the existing therapy gap and to provide protection against a bioterrorism attack using the toxin.

The study is being published the week of February 5 in an online edition of the Proceedings of the National Academy of Sciences.

"Our study is an important milestone in the fight against biological terrorism," said Kim Janda, a Scripps Research scientist who led the study. "These small molecules are the first to show efficacy against this neurotoxin in animal models. Equally important, both have surprisingly simple structures, so their biological activity can be readily optimized. With their different modes of action, they could easily be developed as part of a potent 'cocktail' therapy."

Janda said he expects to develop more small molecule candidates as potential botulism treatments.

Botulinum neurotoxins, which cause the disease botulism, are some of the most toxic substances known to scientists. One subtype, botulinum neurotoxin A, is a 100 billion times more potent than cyanide and relatively easy to produce, making it a potential biological weapon.

Using a multifaceted screening approach, Janda and his colleagues identified the two compounds and tested their efficacy in both cell-based assays and in mice exposed to the toxin.

One compound extended survival time by 36 percent (from 484 minutes to 659 minutes) a remarkable achievement considering its simple structure. Moreover, 16 percent of the animals treated with the second molecule survived with no obvious symptoms of botulism. No significant side effects were observed with either molecule.

Janda pointed out that the two compounds showed surprisingly little activity in cellular assays, suggesting that these standard cell-based screening methods may miss promising therapeutic candidates.

"Our study showed no correlation between cellular activity and in vivo efficacy," Janda said, "which is highly unusual. Clearly, cell-based assays do not provide all the necessary information—animal-based studies are still an essential part of the discovery process. These findings validate our multidisciplinary screening approach to identify unrecognized chemical structures as potential treatments."

While research efforts aimed at finding treatments for bioterrorism agents have increased dramatically since September 11, 2001, remarkably few have emerged. There are currently no small chemical molecules approved for treatment of botulism.

Botulism is a serious but extremely rare illness. There are seven related botulinum neurotoxins (A through G), although each acts differently and only four attack humans. The toxins kill through paralysis of the respiratory muscles. After attaching themselves to receptors on the neuronal surface—primarily muscle controlling motor neurons activated by acetylcholine, a neurotransmitter—the toxins block the release of acetylcholine proteins, inducing paralysis. Approximately 110 cases of botulism are reported each year in the United States.

Source: Scripps Research Institute

Related stories:

Study reveals molecular basis of botulism toxin's deadly activity
In the study, the scientists reveal the mysterious structural basis of the remarkably strong interaction that botulinum toxins form with nerve cells, a union so robust that a single toxin molecule can completely incapacitate a nerve cell. Because of this action, even in minute quantities these toxins are potentially deadly, leading to muscle weakness, paralysis, and sometimes respiratory failure.
Atomic structure of the mammalian 'fatty acid factory' determined
Mammalian fatty acid synthase is one of the most complex molecular synthetic machines in human cells. It is also a promising target for the development of anti-cancer and anti-obesity drugs and the treatment of metabolic disorders. Now researchers at ETH Zurich have determined the atomic structure of a mammalian fatty acid synthase. Their results have just been published in Science magazine.
Scientists peel away the mystery behind gold's catalytic prowess
Few materials have exercised as much of a hold on the human imagination, or on human history, as has gold. But for all of its popular uses – money, medals, jewelry and more – gold's potential as a catalyst lay hidden until the 1980s, when Masatake Haruta and Graham Hutchings independently discovered that gold, which had long been considered inactive, could be an extraordinarily good catalyst. Haruta demonstrated the low-temperature oxidation of CO and Hutchings the hydrochlorination of acetylene to vinyl chloride.
A light bulb and a few chemicals: Scientists find a way to help make new reactions
(PhysOrg.com) -- Princeton scientists have discovered a way of stimulating organic molecules that they expect will prompt researchers to create materials from new kinds of chemical reactions.
Scientists use bacteria to pinpoint chloride toxins
Scientists have studied the sensor with which bacteria detect chloride compounds, many of which can be carcinogenic or dangerous to the environment, and now hope to speed up identification of these dangerous toxins from weeks to just a few hours.
Dr David Leys at the University of Manchester’s Faculty of Life Sciences has won a prestigious European Research Council (ERC) starting grant to further understand this process and to develop a biosensor that will alert us to contamination in environmental or foodstuff samples quickly.
New approach, old drug show promise against hepatitis C, research shows
The fight against the liver disease hepatitis C has been at something of an impasse for years, with more than 150 million people currently infected, and traditional antiviral treatments causing nasty side effects and often falling short of a cure. Using a novel technique, medical and engineering researchers at Stanford University have discovered a vulnerable step in the virus' reproduction process that in lab testing could be effectively targeted with an obsolete antihistamine.
Chemist Discovers the Elusive Chemical Middleman That Removes Acid Rain
(PhysOrg.com) -- Researchers have discovered the middleman in the complex chemical reaction that is essential to the atmosphere's ability to break down pollutants, especially the compounds that cause acid rain. The study improves the basic understanding of the chemical removal of acid rain and will allow scientists to better model how pollutants are removed from the atmosphere and to predict potential environmental conditions.
No more big stink: scent lures mosquitoes, but humans can't smell it
Mosquito traps that reek like latrines may be no more. A University of California, Davis research team led by chemical ecologist Walter Leal has discovered a low-cost, easy-to-prepare attractant that lures blood-fed mosquitoes without making humans hold their noses.

News discussion:

Medicine & Health news